TrialProstate cancer and prostatic diseases2020

A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer.

Ashley E Ross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.